Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Clinitas Ultra 3** is an over-the-counter (OTC) preservative-free ophthalmic lubricant eye drop formulation designed for the relief of mild to severe dry eye symptoms, including grittiness, burning, irritation, and foreign body sensation caused by environmental factors (e.g., wind, sun, air conditioning), visual stress (e.g., computer use), or mechanical factors (e.g., contact lens wear). It targets the tear film's mucin, aqueous, and lipid layers to provide moisturizing, lubricating, and protective effects, offering long-lasting comfort and is compatible with contact lenses. Developed as part of the Clinitas product line by Altacor, a UK-based ophthalmic specialty pharmaceutical company, it features a unique combination addressing multiple causes of dry eye instability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Clinitas Ultra 3.